| 2020 |
Shiraishi K, Chiba K, Okazaki N, Yokota K, Nakazoe Y, Kidera K, Yonekura A, Tomita M, Osaki M. In vivo analysis of subchondral trabecular bone in patients with osteoarthritis of the knee using second-generation high-resolution peripheral quantitative computed tomography (HR-pQCT). Bone. March 2020;132:115155. |
6 |
6 |
| 2021 |
Chiba K, Yamada S, Yoda I, Era M, Yokota K, Okazaki N, Ota S, Isobe Y, Miyazaki S, Tashiro S, Nakashima S, Morimoto S, Sato S, Tsukazaki T, Watanabe T, Enomoto H, Yabe Y, Yonekura A, Tomita M, Ito M, Osaki M. Effects of monthly intravenous ibandronate on bone mineral density and microstructure in patients with primary osteoporosis after teriparatide treatment: the MONUMENT study. Bone. March 2021;144:115770. |
1 |
1 |
| 2021 |
Okazaki N, Chiba K, Burghardt AJ, Kondo C, Doi M, Yokota K, Yonekura A, Tomita M, Osaki M. Differences in bone mineral density and morphometry measurements by fixed versus relative offset methods in high-resolution peripheral quantitative computed tomography. Bone. August 2021;149:115973. |
2 |
1 |
| 2022 |
Doi M, Chiba K, Okazaki N, Kondo C, Yamada S, Yokota K, Yonekura A, Tomita M, Osaki M. Bone microstructure in healthy men measured by HR-pQCT: age-related changes and their relationships with DXA parameters and biochemical markers. Bone. January 2022;154:116252. |
0 |
0 |
| 2022 |
Chiba K, Okazaki N, Kurogi A, Watanabe T, Mori A, Suzuki N, Adachi K, Era M, Yokota K, Inoue T, Yabe Y, Furukawa K, Kondo C, Tsuda K, Ota S, Isobe Y, Miyazaki S, Morimoto S, Sato S, Nakashima S, Tashiro S, Yonekura A, Tomita M, Osaki M. Randomized controlled trial of daily teriparatide, weekly high-dose teriparatide, or bisphosphonate in patients with postmenopausal osteoporosis: the TERABIT study. Bone. July 2022;160:116416. |
1 |
1 |
| 2022 |
Chiba K, Okazaki N, Kurogi A, Watanabe T, Mori A, Suzuki N, Adachi K, Era M, Yokota K, Inoue T, Yabe Y, Furukawa K, Kondo C, Tsuda K, Ota S, Isobe Y, Miyazaki S, Morimoto S, Sato S, Nakashima S; Shigeki Tashiro, Yonekura A, Tomita M, Osaki M. Corrigendum to “Randomized controlled trial of daily teriparatide, weekly high-dose teriparatide, or bisphosphonate in patients with postmenopausal osteoporosis: the TERABIT study” [Bone 160 (2022) 116416]. Bone. September 2022;162:116484. |
0 |
0 |